20-F/A

FORM 20-F AMENDMENT NO. 1

Company: NYMOX PHARMACEUTICAL CORP
Filed: June 19, 2003
Period of Report: December 31, 2002
Accession Number: 0000897069-03-000668

View Document ↗ View on SEC.gov ↗